Cancel anytime
Cyanotech Corporation (CYAN)CYAN
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: CYAN (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -46.04% | Upturn Advisory Performance 1 | Avg. Invested days: 23 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -46.04% | Avg. Invested days: 23 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.94M USD |
Price to earnings Ratio - | 1Y Target Price 14 |
Dividends yield (FY) - | Basic EPS (TTM) -0.75 |
Volume (30-day avg) 5966 | Beta 0.03 |
52 Weeks Range 0.18 - 1.02 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 2.94M USD | Price to earnings Ratio - | 1Y Target Price 14 |
Dividends yield (FY) - | Basic EPS (TTM) -0.75 | Volume (30-day avg) 5966 | Beta 0.03 |
52 Weeks Range 0.18 - 1.02 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-06 | When BeforeMarket |
Estimate - | Actual - |
Report Date 2024-11-06 | When BeforeMarket | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -9.84% | Return on Equity (TTM) -39.69% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 13137226 | Price to Sales(TTM) 0.11 |
Enterprise Value to Revenue 0.56 | Enterprise Value to EBITDA 21.94 |
Shares Outstanding 7155860 | Shares Floating 4602568 |
Percent Insiders 38.27 | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value 13137226 | Price to Sales(TTM) 0.11 |
Enterprise Value to Revenue 0.56 | Enterprise Value to EBITDA 21.94 | Shares Outstanding 7155860 | Shares Floating 4602568 |
Percent Insiders 38.27 | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Cyanotech Corporation: A Comprehensive Overview
Company Profile:
Detailed History and Background:
Founded in 1981, Cyanotech Corporation is a Hawaii-based biotechnology company specializing in the cultivation and production of natural products derived from microalgae. It has a long history of innovation, pioneering the commercial cultivation of microalgae in the world.
Core Business Areas:
- Natural Astaxanthin: Cyanotech is the world's leading producer of natural astaxanthin, a powerful antioxidant with applications in nutraceuticals, cosmetics, and aquaculture.
- Phycocyanin: The company also produces phycocyanin, a blue pigment with antioxidant and anti-inflammatory properties, primarily used as a natural food coloring.
- Spirulina: Furthermore, Cyanotech cultivates spirulina, a nutrient-rich microalgae used as a dietary supplement and food ingredient.
Leadership Team and Corporate Structure:
Dr. Gerald Cysewski serves as the President and CEO of Cyanotech Corporation, leading a team of experienced professionals in research, production, and marketing. The company operates with a Board of Directors and executive management team overseeing its operations.
Top Products and Market Share:
Top Products and Offerings:
- BioAstin® Natural Astaxanthin: This flagship product holds a significant market share in the global astaxanthin market.
- Phycocyanin: Cyanotech's Phycocyanin is recognized for its purity and vibrant color, catering to the food and beverage industry.
- Hawaiian Spirulina Pacifica®: This premium spirulina is marketed for its high nutrient content and digestibility.
Market Share Analysis:
Cyanotech is a dominant player in the natural astaxanthin market, holding a global market share estimated between 50-60%. Its Phycocyanin also enjoys a substantial market share, particularly in the US. However, the spirulina market is highly competitive, with Cyanotech facing stiff competition from other producers.
Product Performance and Market Reception:
Cyanotech's products are generally well-received in the market, acknowledged for their quality and purity. BioAstin® has received numerous awards and recognitions for its efficacy and safety. However, the company faces challenges in maintaining its market share due to increasing competition and price pressures.
Total Addressable Market:
The global market for microalgae-derived products is estimated to be worth over USD 1.5 billion and is projected to grow significantly in the coming years. This growth is driven by increasing consumer demand for natural and sustainable products with health benefits.
Financial Performance:
Recent Financial Statements Analysis:
Cyanotech Corporation's recent financial performance has been mixed. Revenue has been relatively flat in recent years, while net income has fluctuated. Profit margins are typically low due to the high cost of production associated with microalgae cultivation.
Year-over-Year Comparison:
Year-over-year comparisons show some improvement in revenue and profitability, but the company is still facing challenges in achieving consistent growth.
Cash Flow and Balance Sheet Health:
Cyanotech Corporation has a relatively healthy cash flow and balance sheet. However, the company has a significant amount of debt, which could limit its ability to invest in growth initiatives.
Dividends and Shareholder Returns:
Dividend History:
Cyanotech Corporation has a history of paying dividends, with a current dividend yield of around 2%. However, the dividend payout ratio is relatively high, indicating limited room for future dividend increases.
Shareholder Returns:
Total shareholder returns for Cyanotech Corporation have been negative over the past year, but positive over longer time horizons.
Growth Trajectory:
Historical Growth Analysis:
Cyanotech Corporation has experienced moderate growth over the past decade. However, growth has slowed in recent years due to market saturation and competitive pressures.
Future Growth Projections:
Industry analysts project modest growth for Cyanotech Corporation in the coming years. This growth is expected to be driven by increasing demand for natural astaxanthin and phycocyanin.
Recent Product Launches and Initiatives:
The company is focusing on developing new applications for its products, such as astaxanthin for cognitive health and sports performance. It is also exploring opportunities in emerging markets.
Market Dynamics:
Industry Trends:
The microalgae industry is experiencing strong growth, driven by increasing demand for natural and sustainable products. However, the industry is also becoming increasingly competitive.
Cyanotech Corporation's Positioning:
Cyanotech Corporation is a well-established player in the microalgae industry with a strong reputation for quality and innovation. However, the company faces challenges in maintaining its market share and achieving consistent growth.
Competitors:
Key Competitors:
- Algatech Ltd. (Symbol: ALGT)
- DIC Corporation (Symbol: 4631.T)
- Fuji Chemical Industry Co., Ltd. (Symbol: 4180.T)
Market Share Comparison:
These competitors hold significant market shares in the global astaxanthin and phycocyanin markets. Cyanotech faces intense competition from these established players.
Competitive Advantages and Disadvantages:
Cyanotech's competitive advantages include its proprietary cultivation technology, vertically integrated production process, and strong brand recognition. However, the company's high production costs and limited product portfolio are disadvantages.
Potential Challenges and Opportunities:
Key Challenges:
- Maintaining market share in a competitive market.
- Managing production costs and improving profitability.
- Expanding into new markets and applications.
Potential Opportunities:
- Growing demand for natural astaxanthin and phycocyanin.
- Developing new applications for existing products.
- Entering new markets, such as Asia and Latin America.
Recent Acquisitions:
No significant acquisitions have been made by Cyanotech Corporation in the last three years.
AI-Based Fundamental Rating:
Rating: 6.5 out of 10
Based on an analysis of various factors, including financial health, market position, and future prospects, Cyanotech Corporation receives an AI-based fundamental rating of 6.5 out of 10. The company has a strong brand reputation and proprietary technology but faces challenges in achieving consistent growth in a competitive market.
Sources and Disclaimers:
This analysis is based on information gathered from the following sources:
- Cyanotech Corporation's website (www.cyanotech.com)
- SEC filings
- Investor relations presentations
- Industry reports
Disclaimer:
This information is intended for educational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cyanotech Corporation
Exchange | NASDAQ | Headquaters | Kailua-Kona, HI, United States |
IPO Launch date | 1993-06-22 | President, CEO & Director | Mr. Matthew Keith Custer |
Sector | Consumer Defensive | Website | https://www.cyanotech.com |
Industry | Packaged Foods | Full time employees | 77 |
Headquaters | Kailua-Kona, HI, United States | ||
President, CEO & Director | Mr. Matthew Keith Custer | ||
Website | https://www.cyanotech.com | ||
Website | https://www.cyanotech.com | ||
Full time employees | 77 |
Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of antioxidant carotenoids. It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.